Search research articles
Contact Us
Filters
Showing results (31-40 of 122) with videos related to
Page
of 13
Sort By:
Pharmacoeconomics
|
February 18, 2016
Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France
Sylvain Druais, Agathe Doutriaux, Magali Cognet, et al.
Depression and Anxiety
|
April 14, 2025
Use of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression in Routine Practice: A Real-World French Study
Ludovic Samalin, Lila Mekaoui, Maud Rothärmel, et al.
Pharmacoepidemiology and Drug Safety
|
December 13, 2021
Initiation of quarterly palmitate paliperidone in French clinical practice: Results from the observational, cross-sectional OPTIMUS study
Charlotte Gary, Cécile Déal, Jennifer Boursicot-Beuzelin, et al.
International Journal of Psychiatry in Clinical Practice
|
September 3, 2024
Real-world demographic and clinical profiles of patients with treatment-resistant depression initiated on esketamine nasal spray
Ludovic Samalin, Lila Mekaoui, Pierre De Maricourt, et al.
Journal of Epidemiology and Population Health
|
November 3, 2024
From PREMIUM to MyPsy&I®: Transforming mental health care with a digital platform for adaptive PREMs and PROMs
Laurent Boyer, Sara Fernandes, Yann Brousse, et al.
Journal of Psychiatric Research
|
March 14, 2026
Effectiveness and factors associated with esketamine response during the 4-week induction period for treatment-resistant depression: post-hoc analysis of the real-world ESKALE study
Ludovic Samalin, Maud Rothärmel, Lila Mekaoui, et al.
L'Encephale
|
July 3, 2023
[Validated care programs for patients with functional neurological disorders]
Gauthier Rauline, Coraline Hingray, Guilhem Carle-Toulemonde, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
June 18, 2013
A composite scale applied to evaluate anxiety in schizophrenic patients (SAES)
Pierre-Michel Llorca, Christophe Lancon, Olivier Blanc, et al.
Archives of Women'S Mental Health
|
February 17, 2024
French Society for Biological Psychiatry and Neuropsychopharmacology and French-speaking Marcé Society guidelines for the management of mood disorders in women before, during, and after pregnancy
Raoul Belzeaux, Florence Gressier, Ludivine Boudieu, et al.
L'Encephale
|
February 18, 2024
French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and treatment-resistant depression: Update 2024
Antoine Yrondi, Hervé Javelot, Bénédicte Nobile, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 122) with videos related to
Sort By:
Page
of 13
Pharmacoeconomics
|
February 18, 2016
Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France
Sylvain Druais, Agathe Doutriaux, Magali Cognet, et al.
Depression and Anxiety
|
April 14, 2025
Use of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression in Routine Practice: A Real-World French Study
Ludovic Samalin, Lila Mekaoui, Maud Rothärmel, et al.
Pharmacoepidemiology and Drug Safety
|
December 13, 2021
Initiation of quarterly palmitate paliperidone in French clinical practice: Results from the observational, cross-sectional OPTIMUS study
Charlotte Gary, Cécile Déal, Jennifer Boursicot-Beuzelin, et al.
International Journal of Psychiatry in Clinical Practice
|
September 3, 2024
Real-world demographic and clinical profiles of patients with treatment-resistant depression initiated on esketamine nasal spray
Ludovic Samalin, Lila Mekaoui, Pierre De Maricourt, et al.
Journal of Epidemiology and Population Health
|
November 3, 2024
From PREMIUM to MyPsy&I®: Transforming mental health care with a digital platform for adaptive PREMs and PROMs
Laurent Boyer, Sara Fernandes, Yann Brousse, et al.
Journal of Psychiatric Research
|
March 14, 2026
Effectiveness and factors associated with esketamine response during the 4-week induction period for treatment-resistant depression: post-hoc analysis of the real-world ESKALE study
Ludovic Samalin, Maud Rothärmel, Lila Mekaoui, et al.
L'Encephale
|
July 3, 2023
[Validated care programs for patients with functional neurological disorders]
Gauthier Rauline, Coraline Hingray, Guilhem Carle-Toulemonde, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
June 18, 2013
A composite scale applied to evaluate anxiety in schizophrenic patients (SAES)
Pierre-Michel Llorca, Christophe Lancon, Olivier Blanc, et al.
Archives of Women'S Mental Health
|
February 17, 2024
French Society for Biological Psychiatry and Neuropsychopharmacology and French-speaking Marcé Society guidelines for the management of mood disorders in women before, during, and after pregnancy
Raoul Belzeaux, Florence Gressier, Ludivine Boudieu, et al.
L'Encephale
|
February 18, 2024
French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and treatment-resistant depression: Update 2024
Antoine Yrondi, Hervé Javelot, Bénédicte Nobile, et al.
Page
of 13